BRIEF published on 07/24/2024 at 12:35, 2 years ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Merger Financing Nasdaq Biopharmaceutical QTORIN™
PRESS RELEASE published on 07/24/2024 at 12:30, 2 years ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Palvella Therapeutics, Inc. and Pieris Pharmaceuticals, Inc. announce a merger to focus on rare genetic skin diseases with QTORIN™ rapamycin. Joint webcast on July 24 at 8:30am ET Merger Clinical-stage Genetic Skin Diseases QTORIN™ Rapamycin FDA-approved Therapies
BRIEF published on 04/19/2024 at 18:15, 2 years 3 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Reverse Stock Split Nasdaq Compliance Financial Regulation Pieris Pharmaceuticals Stock Adjustment
PRESS RELEASE published on 04/19/2024 at 18:10, 2 years 3 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Pieris Pharmaceuticals, Inc. announces a 1-for-80 reverse stock split effective on April 22, 2024, to comply with Nasdaq listing requirements. No fractional shares will be issued Reverse Stock Split Compliance Nasdaq Pieris Pharmaceuticals Stockholder Ownership
BRIEF published on 03/27/2024 at 13:05, 2 years 4 months ago Pieris Pharmaceuticals Announces New Strategy to Maximize Financial Potential Shareholder Value Pieris Pharmaceuticals Strategic Reorganization Milestone Payments Royalty Potential
PRESS RELEASE published on 03/27/2024 at 13:00, 2 years 4 months ago Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential Pieris Pharmaceuticals, Inc. announces strategic repositioning to maximize milestone and royalty potential from immuno-oncology assets. Cost-saving measures extend cash runway into 2027 Strategic Repositioning Cost-saving Measures Pieris Pharmaceuticals Milestone Payments Immuno-oncology Assets
Published on 07/28/2026 at 23:13, 4 hours 2 minutes ago Nepra Foods Executes Definitive Agreement to Acquire Idaho Beverage Manufacturing Business
Published on 07/28/2026 at 22:05, 5 hours 10 minutes ago Unusual Machines Adopts Performance-Based Executive Compensation
Published on 07/28/2026 at 22:00, 5 hours 15 minutes ago Golden Minerals Reports Second Quarter 2026 Financial Results
Published on 07/28/2026 at 16:55, 10 hours 20 minutes ago Unusual Machines Announces Record Date for 2026 Annual Meeting
Published on 07/29/2026 at 03:05, 10 minutes ago SUNON Unveils ErP 2026-Ready Green EC Fans to Power Next-Gen AI Infrastructure
Published on 07/28/2026 at 20:48, 6 hours 27 minutes ago EQS-Adhoc: Steyr Motors AG: Discussions about possible tender offer for all shares in Steyr Motors AG by Red Cat Holdings, Inc.
Published on 07/28/2026 at 20:38, 6 hours 36 minutes ago Knorr-Bremse sells its global climate control business for trains
Published on 07/28/2026 at 19:49, 7 hours 26 minutes ago Medios AG: Earnings guidance for the financial year 2026 reduced – revenue guidance raised at the same time
Published on 07/28/2026 at 19:21, 7 hours 54 minutes ago Saint-Gobain signs a framework agreement with Microsoft and enhances its leadership in AI for construction
Published on 07/28/2026 at 18:25, 8 hours 50 minutes ago ACCOR - Completion of the 1st tranche of the share buyback programme
Published on 07/28/2026 at 18:00, 9 hours 15 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/06/2026
Published on 07/28/2026 at 18:00, 9 hours 15 minutes ago Deezer delivers sustained Direct growth and profitability, confirms FY26 guidance
